CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
- Authors: Manic, G.; Signore, M.; Sistigu, A.; Russo, G.; Corradi, F.; Siteni, S.; Musella, M.; Vitale, S.; De Angelis, M.; Pallocca, M.; Amoreo, C.; Sperati, F.; DI FRANCO, S.; Barresi, S.; Policicchio, E.; De Luca, G.; De Nicola, F.; Mottolese, M.; Zeuner, A.; Fanciulli, M.; Stassi, G.; Maugeri-saccà , M.; Baiocchi, M.; Tartaglia, M.; Vitale, I.; De Maria, R.
- Publication year: 2018
- Type: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/245924
Abstract
Cancer stem cells (CSCs) are responsible for tumour formation and spreading, and their targeting is required for tumour eradication. There are limited therapeutic options for advanced colorectal cancer (CRC), particularly for tumours carrying RAS-activating mutations. The aim of this study was to identify novel CSC-targeting strategies.